Skip to content
The Nexus
HEALTHJun 1 · 02:50 UTCBBC HEALTH

Daily pill doubles survival time for pancreatic cancer patients

The drug daraxonrasib has been described as a breakthrough in managing pancreatic cancer, with a daily pill doubling survival time for patients. The treatment targets the deadliest of all major cancers.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
daraxonrasibtopicpancreatic cancertopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting